Correlation Between Sonata Software and Akums Drugs
Specify exactly 2 symbols:
By analyzing existing cross correlation between Sonata Software Limited and Akums Drugs and, you can compare the effects of market volatilities on Sonata Software and Akums Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonata Software with a short position of Akums Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonata Software and Akums Drugs.
Diversification Opportunities for Sonata Software and Akums Drugs
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sonata and Akums is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Sonata Software Limited and Akums Drugs and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akums Drugs and Sonata Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonata Software Limited are associated (or correlated) with Akums Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akums Drugs has no effect on the direction of Sonata Software i.e., Sonata Software and Akums Drugs go up and down completely randomly.
Pair Corralation between Sonata Software and Akums Drugs
Assuming the 90 days trading horizon Sonata Software Limited is expected to generate 0.8 times more return on investment than Akums Drugs. However, Sonata Software Limited is 1.25 times less risky than Akums Drugs. It trades about 0.08 of its potential returns per unit of risk. Akums Drugs and is currently generating about -0.07 per unit of risk. If you would invest 50,089 in Sonata Software Limited on August 30, 2024 and sell it today you would earn a total of 13,436 from holding Sonata Software Limited or generate 26.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 65.04% |
Values | Daily Returns |
Sonata Software Limited vs. Akums Drugs and
Performance |
Timeline |
Sonata Software |
Akums Drugs |
Sonata Software and Akums Drugs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sonata Software and Akums Drugs
The main advantage of trading using opposite Sonata Software and Akums Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonata Software position performs unexpectedly, Akums Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akums Drugs will offset losses from the drop in Akums Drugs' long position.Sonata Software vs. JSW Holdings Limited | Sonata Software vs. Nalwa Sons Investments | Sonata Software vs. Kalyani Investment | Sonata Software vs. Pilani Investment and |
Akums Drugs vs. Piramal Enterprises Limited | Akums Drugs vs. Consolidated Construction Consortium | Akums Drugs vs. PB Fintech Limited | Akums Drugs vs. ABM International Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies |